Anne Dormond-Meuwly - Concepedia

Author

Anne Dormond-Meuwly

University Hospital of Lausanne

Also Known As

Anne Dormond-Meuwly

Publications

391

Citations

H-Index

Concepts

All Affiliations

University Hospital of Lausanne University of Lausanne

About

Anne Dormond-Meuwly is an author at University Hospital of Lausanne specializing in tumor biology, medicine, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	152
2	Cell Biology	4	4	126
3	Pharmacology	2	2	78
4	Immunology	1	1	52
5	Cancer Therapeutics	1	1	52

Anne Dormond-Meuwly

Publications

386

Citations

H-Index

Page 1

	Year	Citations
Targeting mTORC2 inhibits colon cancer cell proliferation in vitro and tumor formation in vivo Didier Roulin, Yannick Cerantola, Anne Dormond-Meuwly, Molecular Cancer	2010	88
Targeting renal cell carcinoma with NVP-BEZ235, a dual PI3K/mTOR inhibitor, in combination with sorafenib Didier Roulin, Laurent Waselle, Anne Dormond-Meuwly, Molecular Cancer	2011	70
Targeting the Mammalian Target of Rapamycin (mTOR) in Cancer Therapy: Lessons from Past and Future Perspectives Marc Dufour, Anne Dormond-Meuwly, Nicolas Demartines, Cancers Cancer TherapyFuture PerspectivesImmunologyAllosteric Mtor InhibitorsTumor Biology	2011	52
Antitumor activities of ATP-competitive inhibitors of mTOR in colon cancer cells Benjamin Blaser, Laurent Waselle, Anne Dormond-Meuwly, BMC Cancer	2012	44
PGE2-induced colon cancer growth is mediated by mTORC1 Marc Dufour, Seraina Faes, Anne Dormond-Meuwly, Biochemical and Biophysical Research Communications MedicineColorectal CancerTumor SuppressorCancer BiologyCell Biology	2014	41
Rapamycin-mediated FOXO1 inactivation reduces the anticancer efficacy of rapamycin. Etienne Abdelnour‐Berchtold, Yannick Cerantola, Didier Roulin, PubMed	2010	32
The inhibition of MAPK potentiates the anti-angiogenic efficacy of mTOR inhibitors Anne Dormond-Meuwly, Didier Roulin, Marc Dufour, Biochemical and Biophysical Research Communications Anti-angiogenic EfficacyAngiogenesisMtor InhibitorsCardiovascular DiseasePharmacology	2011	26
Reactivation of AKT signaling following treatment of cancer cells with PI3K inhibitors attenuates their antitumor effects Marc Dufour, Anne Dormond-Meuwly, Catherine Pythoud, Biochemical and Biophysical Research Communications Tumor BiologyPi3k InhibitorsMedicineCell DeathCancer Biology	2013	21
Targeting the JNK Signaling Pathway Potentiates the Antiproliferative Efficacy of Rapamycin in LS174T Colon Cancer Cells M Benoit, Anne Dormond-Meuwly, Nicolas Demartines, Journal of Surgical Research Tumor BiologyJnk Signaling PathwaySignaling PathwayMedicineColorectal Cancer	2011	12

Page 1